Helen Torley - 23 Feb 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
23 Feb 2025
Net transactions value
-$697,678
Form type
4
Filing time
24 Feb 2025, 17:01:43 UTC
Previous filing
21 Feb 2025
Next filing
24 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +22,436 +3.1% $0.000000 745,800 23 Feb 2025 Direct
transaction HALO Common Stock Tax liability $697,678 -12,081 -1.6% $57.75 733,719 23 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -22,436 -25% $0.000000 67,308 23 Feb 2025 Common Stock 22,436 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 12,081 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.